# CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma

> **NCT07659678** · PHASE2 · RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 90 (estimated)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma
- Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
- Head and Neck Squamous Cell Carcinoma HNSCC

## Interventions

- **DRUG:** 64Cu-DOTA-ECL1i

## Key facts

- **NCT ID:** NCT07659678
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-10-31
- **Primary completion:** 2032-05-31
- **Final completion:** 2032-05-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-10-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07659678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07659678, "CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07659678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*